Cargando…
Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade
Epidemiological data from the Indian subcontinent on the burden of Heart failure (HF) is scarce. Mineralocorticoid receptor antagonists (MRAs) are usually used in the management of HF and hypertension. A consortium of experts reviewed and opined on the pathophysiological role of aldosterone in HF an...
Autores principales: | Jadhav, Uday, Nair, Tiny, Mohanan, Padhinhare, Chopra, Vijay, Kerkar, Prafulla, Das Biswas, Arup, Hazra, Prakash K, Zalte, Nitin, Sugumaran, Amarnath, Mohanasundaram, Senthilnathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578196/ https://www.ncbi.nlm.nih.gov/pubmed/37849613 http://dx.doi.org/10.7759/cureus.45241 |
Ejemplares similares
-
The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023) -
Mineralocorticoid receptor antagonist use following heart failure hospitalization
por: Duran, Jason M., et al.
Publicado: (2020) -
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
por: Berbenetz, Nicolas M., et al.
Publicado: (2016) -
Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives
por: Vizzardi, Enrico, et al.
Publicado: (2014) -
Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
por: Henrysson, Josefin, et al.
Publicado: (2022)